Medicis Pharmaceutical Corp (NYSE:MRX)
CAPS Rating:
A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.
RSS Headlines
Fool UK
Recs
Slowed growth in earnings due to increased expenses with LipoSonix acquisition. Whether that business takes off or not, there is very good value here.